Search Results - "Satoshi Nagamori"

Possibility for Dose Optimization of Pazopanib from Its Plasma Concentration in Japanese Patients with Cancer by Tanaka, Hiroyuki, Hiraga, Hiroaki, Takekuma, Yoh, Harabayashi, Toru, Nagamori, Satoshi, Endo, Masayuki, Sugawara, Mitsuru

“…The currently approved dose of pazopanib (800 mg) is being re-examined owing to its adverse effects. The aim of this study was to evaluate the relationships…”
Get full text

A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study by Matsubara, Nobuaki, Kimura, Go, Uemura, Hiroji, Uemura, Hirotsugu, Nakamura, Motonobu, Nagamori, Satoshi, Mizokami, Atsushi, Kikukawa, Hiroaki, Hosono, Makoto, Kinuya, Seigo, Krissel, Heiko, Siegel, Jonathan, Kakehi, Yoshiyuki

“…Background ERA 223 compared concurrent abiraterone acetate/prednisolone (AAP) plus radium-223 with AAP plus placebo in men with chemotherapy-naïve asymptomatic…”
Get full text

Comparative study of lymph node dissection, and oncological outcomes of laparoscopic and open radical nephroureterectomy for patients with urothelial carcinoma of the upper urinary tract undergoing regional lymph node dissection by Abe, Takashige, Kondo, Tsunenori, Harabayashi, Toru, Takada, Norikata, Matsumoto, Ryuji, Osawa, Takahiro, Minami, Keita, Nagamori, Satoshi, Maruyama, Satoru, Murai, Sachiyo, Tanabe, Kazunari, Shinohara, Nobuo

“…We revealed the feasibility of lymph node dissection (LND) with a laparoscopic approach and the equivalent oncological outcome of laparoscopic…”
Get full text

Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer by Suzuki, Hiroyoshi, Uemura, Hiroji, Mizokami, Atsushi, Hayashi, Narihiko, Miyoshi, Yasuhide, Nagamori, Satoshi, Enomoto, Yutaka, Akaza, Hideyuki, Asato, Takayuki, Kitagawa, Tadayuki, Suzuki, Kazuhiro

“…This open‐label, phase I dose‐finding study evaluated the gonadotropin‐releasing hormone antagonist, TAK‐385, in Japanese patients with nonmetastatic prostate…”
Get full text

Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis by Matsumoto, Ryuji, Takada, Norikata, Abe, Takashige, Minami, Keita, Harabayashi, Toru, Nagamori, Satoshi, Hatanaka, Kanako C, Miyajima, Naoto, Tsuchiya, Kunihiko, Maruyama, Satoru, Murai, Sachiyo, Shinohara, Nobuo

“…To investigate node-disease prevalence including micrometastases and its survival impact on bladder cancer patients. A total of 60 patients participated in…”
Get full text

A new and direct preparation method of iron-based bimodal catalyst and its application in Fischer–Tropsch synthesis by Zhang, Yi, Bao, Jun, Nagamori, Satoshi, Tsubaki, Noritatsu

“…Through one-step impregnation, an iron-based bimodal catalyst was prepared by directly using the active components for building up small pores inside the large…”
Get full text

Possibility for Dose Optimization of Pazopanib from Its Plasma Concentration in Japanese Patients with Cancer by Hiroyuki Tanakaa, Hiroaki Hiragab, Yoh Takekumac, Toru Harabayashid, Satoshi Nagamorid, Masayuki Endoa, Mitsuru Sugawarac

“…The currently approved dose of pazopanib (800mg) is being re-examined owing to its adverse effects. The aim of this study was to evaluate the relationships…”
Get full text

Lymphoepithelioma-like carcinoma of the renal pelvis by Haga, Kazunori, Aoyagi, Toshiki, Kashiwagi, Akira, Yamashiro, Katushige, Nagamori, Satoshi

“…:  Lymphoepithelioma‐like carcinoma (LELC), best known to occur in the nasopharynx, can arise in a variety of sites, such as the salivary gland, thymus, lung,…”
Get full text

Prevalence of renal cell carcinoma: A nation-wide survey in Japan, 2002 by Marumo, Ken, Kanayama, Hiroomi, Miyao, Noriomi, Nakazawa, Hayakazu, Ozono, Seiichiro, Horie, Shigeo, Nagamori, Satoshi, Igarashi, Tatsuo, Hasegawa, Michihiko, Kimura, Go, Nakao, Masahiro, Nakamoto, Takahisa, Naito, Seiji

“…Objective:  To investigate the incidence of renal cell carcinoma, classified by sex, age group and region in Japan, following a 5‐year interval after a…”
Get full text

Voided urine cytology and low-grade urothelial neoplasia of the bladder: factors that influence the sensitivity by Yamashiro, Katsushige, MD, Taira, Kiyomi, CT, Nakajima, Manami, CT, Azuma, Manabu, CT, Koseki, Miho, CT, Abe, Tamami, CT, Suzuki, Hiroaki, MD, Minami, Keita, MD, Harabayashi, Toru, MD, Nagamori, Satoshi, MD

“…Introduction The aims of this study were to show the 10-year results of voided urine cytology (VUC) performed using liquid-based cytology (LBC) with CytoRich…”
Get full text

Surgical outcomes of partial nephrectomy for renal cell carcinoma: A joint study by the Japanese Society of Renal Cancer by Senga, Yutaka, Ozono, Seiichiro, Nakazawa, Hayakazu, Nagamori, Satoshi, Marumo, Ken, Horie, Shigeo, Onishi, Tetsuro, Miyao, Noriomi, Nakao, Masahiro, Igarashi, Tatsuo, Tsushima, Tomoyasu, Hasegawa, Michihiko, Murai, Masaru

“…Objective:  A joint study was undertaken by the Japanese Society of Renal Cancer to investigate the present status of partial nephrectomy in Japan and to…”
Get full text

Axitinib-Induced Hypothyroidism as a Predictor of Long-Term Survival in Patients with Metastatic Renal Cell Carcinoma by Takada, Shinya, Hashishita, Hirokazu, Nagamori, Satoshi, Endo, Masayuki

“…The side effects of sunitinib, namely onset of hypertension and hypothyroidism, have been reported to be predictive biomarkers of treatment efficacy. However,…”
Get more information

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial by Petrylak, Daniel P, de Wit, Ronald, Sternberg, Cora N, Nishiyama, Hiroyuki, Castellano, Daniel, Matsubara, Nobuaki, Alekseev, Boris, Necchi, Andrea, Géczi, Lajos, Ou, Yen-Chuan, Coskun, Hasan Senol, Su, Wen-Pin, Hegemann, Miriam, Percent, Ivor J, Lee, Jae-Lyun, Tucci, Marcello, Tortora, Giampaolo, Safina, Sufia, Rodriguez-Vida, Alejo, Harputluoglu, Hakan, Widau, Ryan C, Liepa, Astra M, Hamid, Oday, Zimmermann, Annamaria H, Bell-McGuinn, Katherine M, Wong, Suet-Lai Shirley, Hovey, Elizabeth Jane, Ng, Siobhan Su Wan, Dumez, Herlinde, Cheng, Susanna Yee-Shan, Jensen, Niels Viggo, Laguerre, Brigitte, Culine, Stéphane, Becht, Catherine, Niegisch, Günter, Grimm, Marc-Oliver, Gakis, Georgios, Schultze-Seemann, Wolfgang, Mavroudis, Dimitrios, Révész, Janos, Geczi, Lajos, Rosenbaum, Eli, Kejzman, Daniel, Peer, Avivit, Sarid, David, Tortora, Giampaolo, Bracarda, Sergio, Necchi, Andrea, Massari, Francesco, Osawa, Takahiro, Shinohara, Nobuo, Fukuta, Fumimasa, Obara, Wataru, Tomita, Yoshihiko, Kawai, Koji, Matsubara, Nobuaki, Oyama, Masafumi, Nagata, Masayoshi, Uemura, Motohide, Nishimura, Kazuo, Kawakita, Mutsushi, Inokuchi, Junichi, Yokomizo, Akira, Lee, Jae-Lyun, Park, Se Hoon, Rha, Sun Young, Kim, Yu Jung, Flores, Claudia Lorena Urzua, Blaisse, Reinoud J B, van der Heijden, Michiel S, de Wit, Ronald, Aarts, Maureen J B, Wojcik-Tomaszewska, Joanna, Tomczak, Piotr, Sikora-Kupis, Bozena, Safina, Sufia Z, Alekseev, Boris, Semenov, Andrey, Fomkin, Roman, Del Muro, F Xavier García, Lin, Chien-Liang, Yeh, Su-Peng, Çiçin, Irfan, Harputluoglu, Hakan, Erman, Mustafa, Golovko, Yurii, Bondarenko, Igor, Powles, Thomas, Syndikus, Isabel, Huddart, Robert, Sundar, Santhanam, Chowdhury, Simon, Drakaki, Alexandra, Petrylak, Daniel, Schwarz, James, Percent, Ivor, Hainsworth, John, Herms, Benjamin, Tagawa, Scott, Vaishampayan, Ulka

“…Few treatments with a distinct mechanism of action are available for patients with platinum-refractory advanced or metastatic urothelial carcinoma. We assessed…”
Get full text

A phase II, open-label, multi-arm study of TAS-115 for castration-resistant prostate cancer patients with bone metastases by Uemura, Hiroji, Matsubara, Nobuaki, Uemura, Hirotsugu, Nagamori, Satoshi, Suzuki, Hiroyoshi, Kimura, Go

“…Abstract only 164 Background: TAS-115, a novel multi-kinase (eg, MET, VEGFR) inhibitor has also shown to inhibits Feline McDonough Sarcoma oncogene (FMS)…”
Get full text

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial by Petrylak, Daniel P, de Wit, Ronald, Chi, Kim N, Drakaki, Alexandra, Sternberg, Cora N, Nishiyama, Hiroyuki, Castellano, Daniel, Hussain, Syed A, Fléchon, Aude, van der Heijden, Michiel S, Matsubara, Nobuaki, Necchi, Andrea, Géczi, Lajos, Ou, Yen-Chuan, Coskun, Hasan Senol, Su, Wen-Pin, Percent, Ivor J, Lee, Jae-Lyun, Laestadius, Fredrik, Peer, Avivit, Garcia del Muro, Xavier, Cicin, Irfan, Vaishampayan, Ulka, Aragon-Ching, Jeanny B, Hamid, Oday, Wijayawardana, Sameera, Russo, Francesca, Zimmermann, Annamaria H, Bell-McGuinn, Katherine M, Wong, Suet-Lai Shirley, Tan, Thean Hsiang, Hovey, Elizabeth Jane, Clay, Timothy Dudley, Wan Ng, Siobhan Su, Rutten, Annemie, Dumez, Herlinde, Ferrario, Cristiano, Sengeloev, Lisa, Jensen, Niels Viggo, Thibault, Constance, Laguerre, Brigitte, Joly, Florence, Culine, Stéphane, Becht, Catherine, Niegisch, Günter, Stöckle, Michael, Grimm, Marc-Oliver, Schultze-Seemann, Wolfgang, Kalofonos, Haralambos, Mavroudis, Dimitrios, Karavasilis, Vasilis, Révész, Janos, Leibowitz-Amit, Raya, Kejzman, Daniel, Sarid, David, Massari, Francesco, Osawa, Takahiro, Miyajima, Naoto, Shinohara, Nobuo, Fukuta, Fumimasa, Ohyama, Chikara, Obara, Wataru, Yamashita, Shinichi, Tomita, Yoshihiko, Kawai, Koji, Oyama, Masafumi, Yonese, Junji, Uemura, Motohide, Tsunemori, Hiroyuki, Yokomizo, Akira, Nagamori, Satoshi, Lee, Hyo Jin, Park, Se Hoon, Rha, Sun Young, Kim, Yu Jung, Lee, Yun-Gyoo, Vazquez Cortés, Leticia, Lorena Urzua Flores, Claudia, Blaisse, Reinoud J.B., Aarts, Maureen J.B., Schenker, Michael, Herzal, Alina Amalia, Udrea, Anghel Adrian, Karlov, Petr, Fomkin, Roman, Grande, Enrique, Lin, Chia-Chi, Yeh, Su-Peng, Erman, Mustafa, Urun, Yuksel, Golovko, Yuriy, Sinielnikov, Ivan, Crabb, Simon J., Syndikus, Isabel, Sundar, Santhanam, Pan, Chong Xian, Schwarz, James K., Acs, Peter Istvan, Hainsworth, John D., Lawler, William Eyre

“…Ramucirumab—an IgG1 vascular endothelial growth factor receptor 2 antagonist—plus docetaxel was previously reported to improve progression-free survival in…”
Get full text

Possibility for dose optimization of pazopanib from its plasma concentration in Japanese patients with cancer by Tanaka, Hiroyuki, Hiraga, Hiroaki, Takekuma, Yoh, Harabayashi, Toru, Nagamori, Satoshi, Endo, Masayuki, Sugawara, Mitsuru

“…The currently approved dose of pazopanib (800 mg) is being re-examined owing to its adverse effects. The aim of this study was to evaluate the relationships…”
Get full text

A Phase II, Randomized, Open-Label, Multi-arm Study of TAS-115 for Castration-Resistant Prostate Cancer Patients With Bone Metastases by Matsubara, Nobuaki, Uemura, Hirotsugu, Nagamori, Satoshi, Suzuki, Hiroyoshi, Uemura, Hiroji, Kimura, Go

“…•Castration-resistant prostate cancer often metastasizes to bone.•TAS-115 is an oral multikinase inhibitor with activity against bone metastases.•TAS-115 300…”
Get full text

MP80-12 INTRAOPERATIVE ULTRASONOGRAPHY NAVIGATION USING PARALLEL-SIDE DOCKING TECHNIQUE DURING ROBOTIC-ASSISTED PROSTATECTOMY by Harabayashi, Toru, Minami, Keita, Takada, Norikata, Nagamori, Satoshi

Get full text

Oncologic outcomes of laparoscopic radical nephroureterectomy in conjunction with template-based lymph node dissection: An extended follow-up study by Matsumoto, Ryuji, Abe, Takashige, Takada, Norikata, Minami, Keita, Harabayashi, Toru, Nagamori, Satoshi, Hatanaka, Kanako C., Yamashiro, Katsushige, Kikuchi, Hiroshi, Osawa, Takahiro, Maruyama, Satoru, Shinohara, Nobuo

“…•This study demonstrated by regional template-based LND that a certain proportion of patients had node metastasis (pN+, 7/105, 6.7% and pNmicro+, 5/105, 4.8% )…”
Get full text

Maintenance therapy with bacillus Calmette‐Guérin Connaught strain clearly prolongs recurrence‐free survival following transurethral resection of bladder tumour for non‐muscle‐invasive bladder cancer by Hinotsu, Shiro, Akaza, Hideyuki, Naito, Seiji, Ozono, Seiichiro, Sumiyoshi, Yoshiteru, Noguchi, Sumio, Yamaguchi, Akito, Nagamori, Satoshi, Terai, Akito, Nasu, Yasutomo, Kume, Haruki, Tomita, Yoshihiko, Tanaka, Yoshinori, Samma, Shoji, Uemura, Hirotsugu, Koga, Hirofumi, Tsushima, Tomoyasu

“…Study Type – Therapy (RCT) Level of Evidence 1b OBJECTIVE •  To confirm the recurrence‐preventing efficacy and safety of 18‐month bacillus Calmette‐Guérin…”
Get full text